YKL-40 changes are not detected in post-mortem brain of patients with Alzheimer's disease and frontotemporal lobar degeneration.
Yanaika S Hok-A-HinJeroen J M HoozemansWilliam T HuDorine WoutersJennifer C HowellAlberto RábanoWiesje M van der FlierYolande A L PijnenburgCharlotte E TeunissenMarta Del CampoPublished in: Alzheimer's research & therapy (2022)
Our data suggest that CSF YKL-40 changes may not reflect YKL-40 changes within AD and FTLD pathological brain areas. The YKL-40 reactivity associated with classical CAA hallmarks indicates a possible relationship between YKL-40, neuroinflammation, and vascular pathology.